Skip to main content
Retevmo selpercatinib Home
  • Prescribing Information
  • Patient Prescribing Information
  • Instructions for Use
Menu closed
Retevmo selpercatinib Home
  • Prescribing Information
  • Patient Prescribing Information
  • Instructions for Use
Globe Loading... Reveal available languages
  • House For Patients
    • Understanding Biomarker Testing
    • How Retevmo Works
    • Retevmo in NSCLC
    • Retevmo in Thyroid Cancer
    • Retevmo in Other Cancers
    • Taking Retevmo
    • Savings & Support Resources
    • Patient Story
    • Pricing Information
  • For Healthcare Providers
    • Safety & Tolerability
    • Dosing
    • Savings & Support
Ask Lilly

We're here to help.

Phone Call:
1-800-LillyRx
(1-800-545-5979)
Expand contact lilly

Retevmo Patient Story

Meet Ilana, a real Retevmo patient

When Ilana was 52 years old, she was unexpectedly diagnosed with non-small cell lung cancer (NSCLC). When her cancer spread, a biomarker test revealed that she was RET-positive, making her eligible for Retevmo.

Ilana, a real Retevmo patient

Chapter 1
Meet Ilana, a mother of 5 who’s an active member of her community in Texas and loves spending time outdoors with her family.

00:00-00:15
[Retevmo logo element rotates clockwise]

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: What is Retevmo? Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in:

  • adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that Retevmo is right for you.

It is not known if Retevmo is safe and effective when used in children.

Caption: Individual results may vary. Ilana is an actual Retevmo patient with RET-positive metastatic non-small cell lung cancer (NSCLC). Talk to your doctor to see if Retevmo is right for you. Patient was compensated for her time.

RET=rearranged during transfection.

Caption: Please read and listen to the Indication and Safety Summary following this video.

00:15-00:16
Caption: Ilana’s Story

00:16-00:22
Caption: Chapter I
MY HAPPY PLACE

00:22-00:26
[Ilana sits outdoors, surrounded by mountains on the bank of a flowing stream, accompanied by her dog.]

Ilana: I live life now through the lens of thinking, "If I were a memory…

00:27-00:35

[Ilana sits in her living room with windows and bookshelves behind her.]

Ilana (continuing): …How do I want them to remember me? What I want them to get from me." And that makes life very different.

00:37-00:41

[A video production assistant claps a scene marker in front of Ilana’s smiling face.]

Ilana: I'm Ilana, lucky mother of five precious kids.

00:41-00:47

[Montage of Ilana’s family vacation videos: kids racing on the beach, sledding down a hill, and recording themselves singing together in the woods.]

Audio: Happy family chatter

00:47-00:52

[Ilana seated in her living room.]

Ilana: My family is everything.

00:52-01:10

[Ilana and her family ride their bicycles through their neighborhood. Ilana in the kitchen helps her daughters with their homework and puts together their school lunches.]

Ilana: The love and support and care and joy. I want to be here for weddings. I want to be here to help them with their babies. I want to be here for graduations. I want to be here to help with homework or answer questions or put exactly what they like in their school lunch.

01:10-01:11

[The camera focuses on a note which Ilana has left on top of one of the lunchboxes, inside the main pouch. The note says “Camila, You truly are a “rock star” today. Enjoy! I love you, Mama”.]

Ilana: Put the right note for that day.

01:11-01:16

[Ilana in the kitchen oils a pan to make eggs and pancakes.]

Ilana’s daughter: Hey, Mom, what's for breakfast?

Ilana: Hey, baby. Eggs and pancakes and fruit.

01:16-01:28

[Ilana seated in her living room. Scenes of sunlight spangling through tree limbs, water flowing in stream, Ilana letting the stream water flow over her hand.]

Ilana: If I could probably pick to do anything, I'd pick to go hiking and just be in the quiet of nature. Listening to the leaves rustle or the stream. It's just grounding.

01:28-01:35

[Ilana seated in her living room.]

Ilana: Especially with all this going on, it just feels good to just be, and be in nature.

01:36-01:53

[Ilana in a park with her family, playing with their dog.]

Ilana: The community is what feeds my soul. It's people loving my children like their own, so they barely notice I'm gone. It's my husband showing up in a little bit after working all night long in the hospital and being 100% in it.

01:54-02:01

[Ilana seated in her living room.]

Ilana: I get a lot of joy out of just watching the joy and love around me. That's my happy place.

02:01-02:16

[Ilana and her family riding their bicycles in the neighborhood.]

Ilana: Because you don't know what tomorrow brings, really. Like a cancer diagnosis helps you to see that, make that very real. And it's really all that matters. It's all this. There's nothing else.

02:16-02:19

[The screen flickers as if a “home movie” is ending.]

02:19-02:45
[Retevmo logo in bottom-left of screen; red Lilly logo in bottom right of screen]

Narrator: INDICATION AND SAFETY SUMMARY

RETEVMO® (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that RETEVMO is right for you.

It is not known if RETEVMO is safe and effective when used in children.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

02:45-07:41

Narrator: Warnings - RETEVMO may cause serious side effects, including:

Liver problems: Liver problems (increased liver enzymes) can happen during treatment with RETEVMO and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment with RETEVMO to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:

  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark, “tea-colored” urine
  • sleepiness
  • bleeding or bruising
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your stomach area

Lung problems: RETEVMO may cause severe or life-threatening inflammation (swelling) of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including:

  • shortness of breath
  • cough
  • fever

High blood pressure (hypertension): High blood pressure is common with RETEVMO. It may sometimes be severe. You should check your blood pressure regularly during treatment with RETEVMO. If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:

  • confusion
  • headaches
  • shortness of breath
  • dizziness
  • chest pain

Heart rhythm changes (QT prolongation). RETEVMO may cause very slow, very fast, or irregular heartbeats. Your healthcare provider may perform tests before and during treatment with RETEVMO to check the activity of your heart and the levels of body salts (electrolytes) and thyroid-stimulating hormone (TSH) in your blood. Tell your healthcare provider right away if you get any of the following symptoms:

  • loss of consciousness
  • fainting
  • dizziness
  • a change in the way your heart beats (heart palpitations)

Bleeding problems: RETEVMO can cause bleeding, which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:

  • vomiting blood or if your vomit looks like coffee-grounds
  • pink or brown urine
  • red or black stools that look like tar
  • coughing up blood or blood clots
  • unusual bleeding or bruising of your skin
  • menstrual bleeding that is heavier than normal
  • unusual vaginal bleeding
  • nose bleeds that happen often
  • drowsiness or difficulty being awakened
  • confusion
  • headache
  • change in speech

Allergic reactions: RETEVMO can cause a fever, rash, or pain in muscles or joints, especially during the first month of treatment. Tell your healthcare provider if you get any of these symptoms.

Tumor lysis syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with RETEVMO. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with RETEVMO:

  • nausea
  • vomiting
  • weakness
  • swelling
  • shortness of breath
  • muscle cramps
  • seizures

Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your healthcare provider if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your doctor should tell you when you may start taking RETEVMO again after surgery.

Low thyroid hormone levels in your blood (hypothyroidism). Your healthcare provider will do blood tests to check your thyroid function before and during treatment with RETEVMO. Tell your healthcare provider right away if you develop signs or symptoms of low thyroid hormone levels, including:

  • weight gain
  • feeling cold
  • tiredness that worsens or does not go away
  • constipation

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

07:41-09:15
Narrator: Common side effects
The most common side effects of RETEVMO in adults with solid tumors include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache

The most common severe abnormal laboratory test results with RETEVMO in adults with solid tumors include decreased white blood cell count, increased liver enzymes, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

RETEVMO may affect the ability to have children for both females and males. Talk to your healthcare provider if you want to have children and you are thinking about starting treatment with RETEVMO.

  • RETEVMO can harm your unborn baby. You should not become pregnant during treatment with RETEVMO.
  • If you are able to become pregnant:
    • Your healthcare provider will do a pregnancy test before you start treatment with RETEVMO.
    • You should use effective birth control (contraception) during treatment and for 1 week after your last dose of RETEVMO. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RETEVMO.
  • Males with partners who are able to become pregnant should use effective birth control during treatment with RETEVMO and for 1 week after your last dose of RETEVMO.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

09:15-09:37
Narrator: These are not all the possible side effects with RETEVMO. If you are concerned about side effects, talk to your doctor. Tell your doctor about any side effects you have. You can also report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

09:37-11:33
Narrator: Before using
Before taking RETEVMO, tell your doctor about all your medical conditions, including if you:

  • have liver problems
  • have lung or breathing problems other than lung cancer
  • have high blood pressure
  • have heart problems, including a condition called QT prolongation
  • have bleeding problems
  • plan to have surgery. You should stop taking RETEVMO at least 7 days before your planned surgery.
  • are pregnant or plan to become pregnant. See section above for additional information.
  • are breastfeeding or plan to breastfeed. It is not known if RETEVMO passes into your breast milk. Do not breastfeed during treatment with RETEVMO and for 1 week after your last dose.

Also tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RETEVMO may affect the way other medicines work and other medicines may affect how RETEVMO works, and may increase your risk of side effects.

  • During treatment with RETEVMO, you should avoid taking:
    • St. John’s wort,
    • proton-pump inhibitors (PPIs) such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole,
    • H2 blockers such as famotidine, nizatidine, and cimetidine,
    • antacids that contain aluminum, magnesium, calcium, simethicone, or buffered medicines.

If you cannot avoid taking PPIs, H2 blockers, or antacids, see the “How to take with certain other medicines” section below for more information. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

11:33-13:32
Narrator: How to take RETEVMO

  • Take RETEVMO exactly as your healthcare provider tells you.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with RETEVMO if you have side effects. Do not change your dose or stop taking RETEVMO unless your healthcare provider tells you.
  • Swallow RETEVMO capsules and tablets whole. Do not break, crush, or chew.
  • Do not take or give RETEVMO capsules or tablets if you or your child are unable to swallow.
  • If you or your child are unable to swallow RETEVMO whole or if you or your child has a feeding tube, RETEVMO can be prepared and taken or given as a dispersion using only the RETEVMO 40 mg tablets. See the Instructions for Use that comes with RETEVMO for information about the right way to prepare and take or give a dose of RETEVMO 40 mg tablets.
  • Take RETEVMO with or without food.
  • If you vomit after taking a dose of RETEVMO, do not take an extra dose. Take the next dose of RETEVMO at your scheduled time.
  • Do not take a missed dose of RETEVMO unless it is more than 6 hours until your next scheduled dose.
  • If you take too much RETEVMO, call your healthcare provider or go to the nearest hospital emergency room right away.

How to take RETEVMO with certain other medicines

  • If you take a PPI (such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, or rabeprazole), take RETEVMO with food.
  • If you take an H2 blocker (such as famotidine, nizatidine, or cimetidine), take RETEVMO 2 hours before or 10 hours after taking the H2 blocker.
  • If you take an antacid that contains aluminum, magnesium, calcium, simethicone, or buffered medicines, take RETEVMO 2 hours before or 2 hours after taking the antacid.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:32-13:56
Narrator: Learn more
RETEVMO is a prescription medicine available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets. For more information, call 1-800-545-5979 or go to www.Retevmo.com.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:56-14:21
Narrator: This summary provides basic information about RETEVMO. It does not include all information known about this medicine. Read the information that comes with your medicine each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about RETEVMO and how to take it. Your doctor is the best person to help you decide if RETEVMO is right for you.

Caption: SE CON BS LC NOV2025

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

14:21-14:29
Narrator: RETEVMO® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

14:29-14:33
[Red Lilly logo in middle left of screen; Retevmo logo in middle right of screen]

Narrator: Some voice-over created using AI.

Caption: Lilly | A MEDICINE COMPANY

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: CMAT-08784. 01/2026 ©Lilly USA, LLC 2026. All rights reserved.

Caption: Some voiceover audio created using AI


Chapter 2
Ilana's life was turned upside down when she was diagnosed with NSCLC. After a year, she learned that the cancer had spread and it was time to explore new options.

00:00-00:15
[Retevmo logo rotates clockwise]

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption:Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in:

  • adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread

Your healthcare provider will perform a test to make sure that Retevmo is right for you.

It is not known if Retevmo is safe and effective when used in children.

Caption: Individual results may vary. Ilana is an actual Retevmo patient with RET-positive metastatic non-small cell lung cancer (NSCLC). Talk to your doctor to see if Retevmo is right for you. Patient was compensated for her time.

RET=rearranged during transfection.

Caption: Please read and listen to the Indication and Safety Summary following this video.

00:15-00:17
Caption: Ilana’s Story

00:17-00:20
Caption: Chapter II – A SAD TRUTH

00:20-00:21
[A young girl in a kitchen talks about the friendship bracelets on her arm.]
Girl: This one was from…

00:21-00:25
[The camera pans to reveal the face of Ilana.]
Girl: …someone at camp, and this one was from my counselor at camp.

00:25-00:26
[Another young girl smiles and waves at camera]
Girl: This one was from a friend.

00:26-00:29
[The young girl is seen to be having a conversation with Ilana at the dining table.]
Ilana: I started coughing when I was pregnant with the twins,

00:29-00:32
[Various photos of twin girls; video of girls with their mother; overlaid on children’s drawings in background.]
Ilana: and I had it looked at during that pregnancy.

00:32-00:44
[Ilana hugs girls outside a school and exchanging pecks on the cheeks.]

Ilana: I mean, I had it looked at on and off for over eight years. It turns out the cough had nothing to do with the cancer, but thank goodness I coughed because it's what let me know that you know, it's what made me look into it.

00:44-01:03
[Ilana on couch in living room; camera cuts quickly to close-up of Ilana’s eyes, hands as she stands outdoors amidst trees.]
Ilana: I was diagnosed with metastatic non-small cell lung cancer and the feeling was... scared... alone... It's terrifying. It's shocking because you are alone.

01:03-01:11
[Ilana sitting in living room on the couch.]
Ilana: Like everybody's around you and everybody loves you. But life for everybody goes on if you die. And while that's my…

01:11-01:18
[Camera cut to backyard swimming pool. Daughter sitting on beach surrounded by baby sea turtles; cut to home movie of girls playing projected onto Ilana in a darkened room.]
Ilana: …deepest wish, my biggest fear was dying. And not being here to be with the people I love.

01:21-01:25
[Close up of vegetable garden; metal placard reads “Camila’s Garden” and withering plants.]
Ilana: I was told at one point that my chance of survival was very low.

01:26-01:39
[Ilana sitting in living room; cut to close up of dripping faucet; cut to kitchen with dirty dishes with the swimming pool in the background.]
Ilana: And it... it made me sick. Like I got sick and I almost passed out in front of my three little kids and one morning while I was making them breakfast.

01:40-01:42
[Darkened house with dog whimpering; cut to Ilana with her husband; cut to girls playing in soccer game at night.]
Ilana: There was a time when I couldn't go hiking and I just couldn't do what I wanted to do. And I wondered if, you know, would I make it to the next soccer game…

01:51-01:59
[Girls dancing; Ilana hugging her adult son.]
Ilana: …or dance recital or even to my son's wedding. Like, how could I possibly not be at the wedding?

02:00-02:02
[Video of treetops, with screen within screen showing more treetops.]
Ilana: My lung surgery was quick and sweet,

02:02-02:22
[Ilana seen from the side view sitting in living room with a mirror on the wall in the background; cut to Ilana with front view with a bookshelf in the background]
Ilana: …and then we learned that it was in two lymph nodes. So l had to do chemo and they found it in my liver. I had liver surgery. I thought that was all. I then found out it had gone to my brain. I mean, I don't even know what the words are to explain. When you hear, "brain tumor." Like, it doesn't get worse than that.

02:22-02:26
[Ilana sits on couch with her two girls sharing a blanket; cut to preparing meals around the house; cut to Ilana sitting on a swing with her kids; cut to kids playing in the backyard on a see-saw; cut to hosting a birthday party.]
Ilana: And I still had to wake up every morning and be okay for my kids and lay in bed every night and cry with my husband.

02:29-02:34
[Husband reads a story to daughter; sound of film reel coming to an end and screen fades to white.]
Audio: Dan reads a story to his daughter

02:34-08:01
[Retevmo logo in bottom-left of screen; red Lilly logo in bottom right of screen]
Narrator: INDICATION AND SAFETY SUMMARY

RETEVMO® (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that RETEVMO is right for you.

It is not known if RETEVMO is safe and effective when used in children.

Warnings - RETEVMO may cause serious side effects, including:

Liver problems: Liver problems (increased liver enzymes) can happen during treatment with RETEVMO and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment with RETEVMO to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:

  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark, “tea-colored” urine
  • sleepiness
  • bleeding or bruising
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your stomach area

Lung problems: RETEVMO may cause severe or life-threatening inflammation (swelling) of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including:

  • shortness of breath
  • cough
  • fever

High blood pressure (hypertension): High blood pressure is common with RETEVMO. It may sometimes be severe. You should check your blood pressure regularly during treatment with RETEVMO. If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:

  • confusion
  • headaches
  • shortness of breath
  • dizziness
  • chest pain

Heart rhythm changes (QT prolongation). RETEVMO may cause very slow, very fast, or irregular heartbeats. Your healthcare provider may perform tests before and during treatment with RETEVMO to check the activity of your heart and the levels of body salts (electrolytes) and thyroid-stimulating hormone (TSH) in your blood. Tell your healthcare provider right away if you get any of the following symptoms:

  • loss of consciousness
  • fainting
  • dizziness
  • a change in the way your heart beats (heart palpitations)

Bleeding problems: RETEVMO can cause bleeding, which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:

  • vomiting blood or if your vomit looks like coffee-grounds
  • pink or brown urine
  • red or black stools that look like tar
  • coughing up blood or blood clots
  • unusual bleeding or bruising of your skin
  • menstrual bleeding that is heavier than normal
  • unusual vaginal bleeding
  • nose bleeds that happen often
  • drowsiness or difficulty being awakened
  • confusion
  • headache
  • change in speech

Allergic reactions: RETEVMO can cause a fever, rash, or pain in muscles or joints, especially during the first month of treatment. Tell your healthcare provider if you get any of these symptoms.

Tumor lysis syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with RETEVMO. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with RETEVMO:

  • nausea
  • vomiting
  • weakness
  • swelling
  • shortness of breath
  • muscle cramps
  • seizures

Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your healthcare provider if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your doctor should tell you when you may start taking RETEVMO again after surgery.

Low thyroid hormone levels in your blood (hypothyroidism). Your healthcare provider will do blood tests to check your thyroid function before and during treatment with RETEVMO. Tell your healthcare provider right away if you develop signs or symptoms of low thyroid hormone levels, including:

  • weight gain
  • feeling cold
  • tiredness that worsens or does not go away
  • constipation

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

08:01-11:59
Narrator: Common side effects
The most common side effects of RETEVMO in adults with solid tumors include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache

The most common severe abnormal laboratory test results with RETEVMO in adults with solid tumors include decreased white blood cell count, increased liver enzymes, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

RETEVMO may affect the ability to have children for both females and males. Talk to your healthcare provider if you want to have children and you are thinking about starting treatment with RETEVMO.

  • RETEVMO can harm your unborn baby. You should not become pregnant during treatment with RETEVMO.
  • If you are able to become pregnant:
    • Your healthcare provider will do a pregnancy test before you start treatment with RETEVMO.
    • You should use effective birth control (contraception) during treatment and for 1 week after your last dose of RETEVMO. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RETEVMO.
  • Males with partners who are able to become pregnant should use effective birth control during treatment with RETEVMO and for 1 week after your last dose of RETEVMO.

These are not all the possible side effects with RETEVMO. If you are concerned about side effects, talk to your doctor. Tell your doctor about any side effects you have. You can also report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using
Before taking RETEVMO, tell your doctor about all your medical conditions, including if you:

  • have liver problems
  • have lung or breathing problems other than lung cancer
  • have high blood pressure
  • have heart problems, including a condition called QT prolongation
  • have bleeding problems
  • plan to have surgery. You should stop taking RETEVMO at least 7 days before your planned surgery.
  • are pregnant or plan to become pregnant. See section above for additional information.
  • are breastfeeding or plan to breastfeed. It is not known if RETEVMO passes into your breast milk. Do not breastfeed during treatment with RETEVMO and for 1 week after your last dose.

Also tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RETEVMO may affect the way other medicines work and other medicines may affect how RETEVMO works, and may increase your risk of side effects.

  • During treatment with RETEVMO, you should avoid taking:
    • St. John’s wort,
    • proton-pump inhibitors (PPIs) such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole,
    • H2 blockers such as famotidine, nizatidine, and cimetidine,
    • antacids that contain aluminum, magnesium, calcium, simethicone, or buffered medicines.

If you cannot avoid taking PPIs, H2 blockers, or antacids, see the “How to take with certain other medicines” section below for more information. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

11:59-14:24
Narrator: How to take RETEVMO

  • Take RETEVMO exactly as your healthcare provider tells you.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with RETEVMO if you have side effects. Do not change your dose or stop taking RETEVMO unless your healthcare provider tells you.
  • Swallow RETEVMO capsules and tablets whole. Do not break, crush, or chew.
  • Do not take or give RETEVMO capsules or tablets if you or your child are unable to swallow.
  • If you or your child are unable to swallow RETEVMO whole or if you or your child has a feeding tube, RETEVMO can be prepared and taken or given as a dispersion using only the RETEVMO 40 mg tablets. See the Instructions for Use that comes with RETEVMO for information about the right way to prepare and take or give a dose of RETEVMO 40 mg tablets.
  • Take RETEVMO with or without food.
  • If you vomit after taking a dose of RETEVMO, do not take an extra dose. Take the next dose of RETEVMO at your scheduled time.
  • Do not take a missed dose of RETEVMO unless it is more than 6 hours until your next scheduled dose.
  • If you take too much RETEVMO, call your healthcare provider or go to the nearest hospital emergency room right away.

How to take RETEVMO with certain other medicines

  • If you take a PPI (such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, or rabeprazole), take RETEVMO with food.
  • If you take an H2 blocker (such as famotidine, nizatidine, or cimetidine), take RETEVMO 2 hours before or 10 hours after taking the H2 blocker.
  • If you take an antacid that contains aluminum, magnesium, calcium, simethicone, or buffered medicines, take RETEVMO 2 hours before or 2 hours after taking the antacid.

Learn more
RETEVMO is a prescription medicine available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets. For more information, call 1-800-545-5979 or go to www.Retevmo.com.

This summary provides basic information about RETEVMO. It does not include all information known about this medicine. Read the information that comes with your medicine each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about RETEVMO and how to take it. Your doctor is the best person to help you decide if RETEVMO is right for you.

Caption: SE CON BS LC NOV2025

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

14:24-14:32
RETEVMO® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine
Caption: Lilly | A MEDICINE COMPANY

14:32-14:36
[The screen fades to red Lilly logo in middle left of screen; Retevmo logo in middle right of screen]
Caption: Lilly | A MEDICINE COMPANY
Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: CMAT-08785 01/2026 ©Lilly USA, LLC 2026. All rights reserved.

Caption: Some voice-over audio created using AI


Chapter 3
Through biomarker testing, Ilana discovered that she was RET-positive. Though RET is a less common mutation, this diagnosis meant she was eligible to take Retevmo.

00:00-00:15
[Retevmo logo element rotates clockwise]

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: What is Retevmo?

Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in:

  • adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread

Your healthcare provider will perform a test to make sure that Retevmo is right for you.

It is not known if Retevmo is safe and effective when used in children.

Caption: Individual results may vary. Ilana is an actual Retevmo patient with RET-positive metastatic non-small cell lung cancer (NSCLC). Talk to your doctor to see if Retevmo is right for you. Patient was compensated for her time.

RET=rearranged during transfection.

Caption: Please read and listen to the Indication and Safety Summary following this video.

00:15-00:17
Caption: Ilana’s Story

00:17-00:22
Caption: Chapter III – THE TRUE TEST

00:22-00:26
[City skyline in twilight in the background]

Ilana: I walked into the kids' room and they were little and sleeping.

00:27-00:33
[Ilana sitting on couch in living room]

Ilana: And I just looked at them and thought, "How long will I be here?"

00:34-00:44
[Ilana’s daughters playing on a trampoline in their backyard]

Ilana: Will I get to see them grow up? Will I be here, you know, in four months? Will I be here in six months? You know, like…

00:44-00:46
[Ilana’s daughters jumping in a muddy puddle in a park]

Ilana: …how long do I have to tell them…

00:46-00:49
[Ilana sitting on couch in living room]

Ilana: …what I want to give them during that time?

00:50-00:56
[Ilana cuddling with her daughter]

Ilana: You know, nobody else knows how to hold one of them when they're feeling really sad.

00:56-00:59
[Ilana sitting on couch in living room]

Ilana: You know, nobody else is the mom. So...

00:59-01:05
[Ilana with girls working in the garden]

Ilana: When I was diagnosed…

01:05-01:21
[Ilana putting on hiking boots and then going hiking by a river in winter, alone]

Ilana: …it was a shock because I was healthy. That's the weird thing about cancer. You're healthy until you're really not. You know, initially, Dan used to tell me it's going to be okay. And that made me crazy because he had no way to know.

01:21-01:28
[Ilana sitting by the river after her hike, soaking up the winter sun]

Ilana: Nobody can tell you it's going to be okay. Thankfully, a friend of mine told me about biomarker testing.

01:28-01:32
[Close-up of a bunch of violet flowers on their stalk]

Ilana: So I talked to my doctor about it and I was able to get tested.

01:32-01:45
[Ilana’s daughters gardening]

Ilana: Thanks to the test, I found out that my tumor was RET-positive. It meant that I had a biomarker that could be treated with RETEVMO.

01:45-01:48
[Ilana sitting on couch in living room]

Ilana: You know and I just feel like it's going to be okay.

01:48-02:05
[Ilana working in the garden with daughters, who spray her with a hose; sound of film reel coming to an end and screen fades to white]

Ilana: And every step of the journey, and it's been treatable, which is amazing.

02:05-02:30

[Retevmo logo in bottom-left of screen; red Lilly logo in bottom right of screen]

Narrator: INDICATION AND SAFETY SUMMARY

RETEVMO® (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that RETEVMO is right for you.

It is not known if RETEVMO is safe and effective when used in children.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

02:30-07:25
Narrator: Warnings - RETEVMO may cause serious side effects, including:
Liver problems: Liver problems (increased liver enzymes) can happen during treatment with RETEVMO and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment with RETEVMO to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:

  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark, “tea-colored” urine
  • sleepiness
  • bleeding or bruising
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your stomach area

Lung problems: RETEVMO may cause severe or life-threatening inflammation (swelling) of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including:

  • shortness of breath
  • cough
  • fever

High blood pressure (hypertension): High blood pressure is common with RETEVMO. It may sometimes be severe. You should check your blood pressure regularly during treatment with RETEVMO. If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:

  • confusion
  • headaches
  • shortness of breath
  • dizziness
  • chest pain

Heart rhythm changes (QT prolongation). RETEVMO may cause very slow, very fast, or irregular heartbeats. Your healthcare provider may perform tests before and during treatment with RETEVMO to check the activity of your heart and the levels of body salts (electrolytes) and thyroid-stimulating hormone (TSH) in your blood. Tell your healthcare provider right away if you get any of the following symptoms:

  • loss of consciousness
  • fainting
  • dizziness
  • a change in the way your heart beats (heart palpitations)

Bleeding problems: RETEVMO can cause bleeding, which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:

  • vomiting blood or if your vomit looks like coffee-grounds
  • pink or brown urine
  • red or black stools that look like tar
  • coughing up blood or blood clots
  • unusual bleeding or bruising of your skin
  • menstrual bleeding that is heavier than normal
  • unusual vaginal bleeding
  • nose bleeds that happen often
  • drowsiness or difficulty being awakened
  • confusion
  • headache
  • change in speech

Allergic reactions: RETEVMO can cause a fever, rash, or pain in muscles or joints, especially during the first month of treatment. Tell your healthcare provider if you get any of these symptoms.

Tumor lysis syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with RETEVMO. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with RETEVMO:

  • nausea
  • vomiting
  • weakness
  • swelling
  • shortness of breath
  • muscle cramps
  • seizures

Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your healthcare provider if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your doctor should tell you when you may start taking RETEVMO again after surgery.

Low thyroid hormone levels in your blood (hypothyroidism). Your healthcare provider will do blood tests to check your thyroid function before and during treatment with RETEVMO. Tell your healthcare provider right away if you develop signs or symptoms of low thyroid hormone levels, including:

  • weight gain
  • feeling cold
  • tiredness that worsens or does not go away
  • constipation

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

07:25-09:00
Narrator: Common side effects
The most common side effects of RETEVMO in adults with solid tumors include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache

The most common severe abnormal laboratory test results with RETEVMO in adults with solid tumors include decreased white blood cell count, increased liver enzymes, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

RETEVMO may affect the ability to have children for both females and males. Talk to your healthcare provider if you want to have children and you are thinking about starting treatment with RETEVMO.

  • RETEVMO can harm your unborn baby. You should not become pregnant during treatment with RETEVMO.
  • If you are able to become pregnant:
    • Your healthcare provider will do a pregnancy test before you start treatment with RETEVMO.
    • You should use effective birth control (contraception) during treatment and for 1 week after your last dose of RETEVMO. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RETEVMO.
  • Males with partners who are able to become pregnant should use effective birth control during treatment with RETEVMO and for 1 week after your last dose of RETEVMO.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

09:00-09:22
Narrator: These are not all the possible side effects with RETEVMO. If you are concerned about side effects, talk to your doctor. Tell your doctor about any side effects you have. You can also report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

09:22-11:18
Narrator: Before using
Before taking RETEVMO, tell your doctor about all your medical conditions, including if you:

  • have liver problems
  • have lung or breathing problems other than lung cancer
  • have high blood pressure
  • have heart problems, including a condition called QT prolongation
  • have bleeding problems
  • plan to have surgery. You should stop taking RETEVMO at least 7 days before your planned surgery.
  • are pregnant or plan to become pregnant. See section above for additional information.
  • are breastfeeding or plan to breastfeed. It is not known if RETEVMO passes into your breast milk. Do not breastfeed during treatment with RETEVMO and for 1 week after your last dose.

Also tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RETEVMO may affect the way other medicines work and other medicines may affect how RETEVMO works, and may increase your risk of side effects.

  • During treatment with RETEVMO, you should avoid taking:
    • St. John’s wort,
    • proton-pump inhibitors (PPIs) such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole,
    • H2 blockers such as famotidine, nizatidine, and cimetidine,
    • antacids that contain aluminum, magnesium, calcium, simethicone, or buffered medicines.

If you cannot avoid taking PPIs, H2 blockers, or antacids, see the “How to take with certain other medicines” section below for more information. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

11:18-13:16
How to take RETEVMO

  • Take RETEVMO exactly as your healthcare provider tells you.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with RETEVMO if you have side effects. Do not change your dose or stop taking RETEVMO unless your healthcare provider tells you.
  • Swallow RETEVMO capsules and tablets whole. Do not break, crush, or chew.
  • Do not take or give RETEVMO capsules or tablets if you or your child are unable to swallow.
  • If you or your child are unable to swallow RETEVMO whole or if you or your child has a feeding tube, RETEVMO can be prepared and taken or given as a dispersion using only the RETEVMO 40 mg tablets. See the Instructions for Use that comes with RETEVMO for information about the right way to prepare and take or give a dose of RETEVMO 40 mg tablets.
  • Take RETEVMO with or without food.
  • If you vomit after taking a dose of RETEVMO, do not take an extra dose. Take the next dose of RETEVMO at your scheduled time.
  • Do not take a missed dose of RETEVMO unless it is more than 6 hours until your next scheduled dose.
  • If you take too much RETEVMO, call your healthcare provider or go to the nearest hospital emergency room right away.

How to take RETEVMO with certain other medicines

  • If you take a PPI (such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, or rabeprazole), take RETEVMO with food.
  • If you take an H2 blocker (such as famotidine, nizatidine, or cimetidine), take RETEVMO 2 hours before or 10 hours after taking the H2 blocker.
  • If you take an antacid that contains aluminum, magnesium, calcium, simethicone, or buffered medicines, take RETEVMO 2 hours before or 2 hours after taking the antacid.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:16-13:40
Narrator: Learn more
RETEVMO is a prescription medicine available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets. For more information, call 1-800-545-5979 or go to www.Retevmo.com.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:40-13:55
Narrator: This summary provides basic information about RETEVMO. It does not include all information known about this medicine. Read the information that comes with your medicine each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about RETEVMO and how to take it. Your doctor is the best person to help you decide if RETEVMO is right for you.

Caption: SE CON BS LC NOV2025

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

14:07-14:15
Narrator: RETEVMO® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

14:15-14:21
[Red Lilly logo in middle left of screen; Retevmo logo in middle right of screen]
Caption: Lilly | A MEDICINE COMPANY
Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: CMAT-08786 01/2026 ©Lilly USA, LLC 2026. All rights reserved.

Caption: Some voiceover audio created using AI


Chapter 4
From diagnosis to today, Ilana discusses how NSCLC and a RET-positive diagnosis have changed her perspective on what’s most important in life.

00:00-00:15
[Retevmo logo element rotates clockwise]

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: What is Retevmo?
Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in:

  • adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that Retevmo is right for you.

It is not known if Retevmo is safe and effective when used in children.

Caption: Individual results may vary. Ilana is an actual Retevmo patient with RET-positive metastatic non-small cell lung cancer (NSCLC). Talk to your doctor to see if Retevmo is right for you. Patient was compensated for her time. RET=rearranged during transfection.

Caption: Please read and listen to the Indication and Safety Summary following this video.

00:15-00:18
Caption: Ilana’s Story

00:18-00:21
Caption: Chapter IV – A GIFT

00:21-00:36
[Ilana hiking in winter attire amidst trees; swinging from a tree branch, then from a trapeze line; Ilana with daughters]

Ilana: I'm so grateful that I found out that I was RET positive, and that I have access to treatments that allow me to live really happy and allowing me to enjoy my family and my community and my friends and my world.

00:36-00:38
[Ilana playing with her daughter outdoors]
Ilana: It's a gift.

00:38-00:47
[Ilana and husband mingling with guests at a party]

Ilana: I want people to really know that the targeted medicines like RETEVMO exist and that biomarker testing is essential.

Caption: Retevmo may affect both healthy cells and tumor cells, which can result in side effects, some of which can be serious.

00:47-00:52
[Ilana sitting on couch in living room]

Ilana: And it's not that the fear ever goes away. Because it's real and it's scary.

00:52-00:58
[Ilana partying with her family in their backyard by the pool at night clicking polaroid shots]

Ilana: That's what keeps me apologizing to my kids when I use a voice I didn't want to use.

00:58-01:09
[Ilana and her husband hugging and kissing as their daughter takes their photo]

Ilana: That's what keeps me making a point to make dates with my husband, because there is the reality of having a disease that is unpredictable.

01:09-01:12
[Ilana and her husband mingling with guests at a party]

But you know what, I wake up every day…

01:13-01:28
[Ilana and her family having a pillow fight, laughing together]

Ilana: …You know, joyful and ready to be with my children and my husband and my wonderful village of precious friends who, you know, just support us. And we're just a community and…

01:28-01:40
[Ilana sitting on couch in living room]

Ilana: life's fragile. And we're lucky to be alive and together and healthy and planning weddings and, you know, crying over scraped knees and, you know, just living life.

01:40-01:52
[Ilana standing with her family, smiling and laughing in a party]

01:52-02:17
[Retevmo logo in bottom-left of screen; red Lilly logo in bottom right of screen]

Caption: INDICATION AND SAFETY SUMMARY

RETEVMO® (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Your healthcare provider will perform a test to make sure that RETEVMO is right for you.

It is not known if RETEVMO is safe and effective when used in children.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

02:17-07:18
Narrator: Warnings - RETEVMO may cause serious side effects, including:

Liver problems: Liver problems (increased liver enzymes) can happen during treatment with RETEVMO and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment with RETEVMO to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:

  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark, “tea-colored” urine
  • sleepiness
  • bleeding or bruising
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your stomach area

Lung problems: RETEVMO may cause severe or life-threatening inflammation (swelling) of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including:

  • shortness of breath
  • cough
  • fever

High blood pressure (hypertension): High blood pressure is common with RETEVMO. It may sometimes be severe. You should check your blood pressure regularly during treatment with RETEVMO. If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:

  • confusion
  • headaches
  • shortness of breath
  • dizziness
  • chest pain

Heart rhythm changes (QT prolongation). RETEVMO may cause very slow, very fast, or irregular heartbeats. Your healthcare provider may perform tests before and during treatment with RETEVMO to check the activity of your heart and the levels of body salts (electrolytes) and thyroid-stimulating hormone (TSH) in your blood. Tell your healthcare provider right away if you get any of the following symptoms:

  • loss of consciousness
  • fainting
  • dizziness
  • a change in the way your heart beats (heart palpitations)

Bleeding problems: RETEVMO can cause bleeding, which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:

  • vomiting blood or if your vomit looks like coffee-grounds
  • pink or brown urine
  • red or black stools that look like tar
  • coughing up blood or blood clots
  • unusual bleeding or bruising of your skin
  • menstrual bleeding that is heavier than normal
  • unusual vaginal bleeding
  • nose bleeds that happen often
  • drowsiness or difficulty being awakened
  • confusion
  • headache
  • change in speech

Allergic reactions: RETEVMO can cause a fever, rash, or pain in muscles or joints, especially during the first month of treatment. Tell your healthcare provider if you get any of these symptoms.

Tumor lysis syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with RETEVMO. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with RETEVMO:

  • nausea
  • vomiting
  • weakness
  • swelling
  • shortness of breath
  • muscle cramps
  • seizures

Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your healthcare provider if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your doctor should tell you when you may start taking RETEVMO again after surgery.

Low thyroid hormone levels in your blood (hypothyroidism). Your healthcare provider will do blood tests to check your thyroid function before and during treatment with RETEVMO. Tell your healthcare provider right away if you develop signs or symptoms of low thyroid hormone levels, including:

  • weight gain
  • feeling cold
  • tiredness that worsens or does not go away
  • constipation

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

07:18-08:57
Narrator: Common side effects
The most common side effects of RETEVMO in adults with solid tumors include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache

The most common severe abnormal laboratory test results with RETEVMO in adults with solid tumors include decreased white blood cell count, increased liver enzymes, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

RETEVMO may affect the ability to have children for both females and males. Talk to your healthcare provider if you want to have children and you are thinking about starting treatment with RETEVMO.

  • RETEVMO can harm your unborn baby. You should not become pregnant during treatment with RETEVMO.
  • If you are able to become pregnant:
    • Your healthcare provider will do a pregnancy test before you start treatment with RETEVMO.
    • You should use effective birth control (contraception) during treatment and for 1 week after your last dose of RETEVMO. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RETEVMO.
  • Males with partners who are able to become pregnant should use effective birth control during treatment with RETEVMO and for 1 week after your last dose of RETEVMO.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

08:57-09:19
Narrator: These are not all the possible side effects with RETEVMO. If you are concerned about side effects, talk to your doctor. Tell your doctor about any side effects you have. You can also report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

09:19-11:16
Narrator: Before using
Before taking RETEVMO, tell your doctor about all your medical conditions, including if you:

  • have liver problems
  • have lung or breathing problems other than lung cancer
  • have high blood pressure
  • have heart problems, including a condition called QT prolongation
  • have bleeding problems
  • plan to have surgery. You should stop taking RETEVMO at least 7 days before your planned surgery.
  • are pregnant or plan to become pregnant. See section above for additional information.
  • are breastfeeding or plan to breastfeed. It is not known if RETEVMO passes into your breast milk. Do not breastfeed during treatment with RETEVMO and for 1 week after your last dose.

Also tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RETEVMO may affect the way other medicines work and other medicines may affect how RETEVMO works, and may increase your risk of side effects.

  • During treatment with RETEVMO, you should avoid taking:
    • St. John’s wort,
    • proton-pump inhibitors (PPIs) such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole,
    • H2 blockers such as famotidine, nizatidine, and cimetidine,
    • antacids that contain aluminum, magnesium, calcium, simethicone, or buffered medicines.

If you cannot avoid taking PPIs, H2 blockers, or antacids, see the “How to take with certain other medicines” section below for more information. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

11:16-12:48
Narrator: How to take RETEVMO

  • Take RETEVMO exactly as your healthcare provider tells you.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with RETEVMO if you have side effects. Do not change your dose or stop taking RETEVMO unless your healthcare provider tells you.
  • Swallow RETEVMO capsules and tablets whole. Do not break, crush, or chew.
  • Do not take or give RETEVMO capsules or tablets if you or your child are unable to swallow.
  • If you or your child are unable to swallow RETEVMO whole or if you or your child has a feeding tube, RETEVMO can be prepared and taken or given as a dispersion using only the RETEVMO 40 mg tablets. See the Instructions for Use that comes with RETEVMO for information about the right way to prepare and take or give a dose of RETEVMO 40 mg tablets.
  • Take RETEVMO with or without food.
  • If you vomit after taking a dose of RETEVMO, do not take an extra dose. Take the next dose of RETEVMO at your scheduled time.
  • Do not take a missed dose of RETEVMO unless it is more than 6 hours until your next scheduled dose.
  • If you take too much RETEVMO, call your healthcare provider or go to the nearest hospital emergency room right away.

How to take RETEVMO with certain other medicines

  • If you take a PPI (such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, or rabeprazole), take RETEVMO with food.
  • If you take an H2 blocker (such as famotidine, nizatidine, or cimetidine), take RETEVMO 2 hours before or 10 hours after taking the H2 blocker.
  • If you take an antacid that contains aluminum, magnesium, calcium, simethicone, or buffered medicines, take RETEVMO 2 hours before or 2 hours after taking the antacid.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

12:48-13:13
Narrator: Learn more
RETEVMO is a prescription medicine available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets. For more information, call 1-800-545-5979 or go to www.Retevmo.com.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:13-13:42
Narrator: This summary provides basic information about RETEVMO. It does not include all information known about this medicine. Read the information that comes with your medicine each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about RETEVMO and how to take it. Your doctor is the best person to help you decide if RETEVMO is right for you.

Caption: SE CON BS LC NOV2025

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:42-13:50
Narrator: RETEVMO® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Lilly | A MEDICINE COMPANY

13:50-13:56
[Red Lilly logo in middle left of screen; Retevmo logo in middle right of screen]

Caption: Lilly | A MEDICINE COMPANY

Caption: Retevmo® | selpercatinib tablets | 40 mg • 80 mg • 120 mg • 160 mg | A Lilly Medicine

Caption: Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Caption: CMAT-08739 01/2026 ©Lilly USA, LLC 2026. All rights reserved.

Caption: Some voiceover audio created using AI

Ask your doctor about biomarker testing for RET and see if Retevmo is right for you

SELECT SAFETY INFORMATION

RETEVMO may cause serious side effects, including:
Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your doctor if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your doctor should tell you when you may start taking RETEVMO again after surgery.
Retevmo in NSCLC

See how Retevmo may help people living with RET-positive advanced NSCLC

Retevmo in thyroid cancer

See how Retevmo may help people living with RET-positive advanced thyroid cancer

Retevmo in other cancers

See how Retevmo may help people living with certain other RET-positive advanced cancers

Warnings - RETEVMO may cause serious side effects, including:

 

Liver problems: Liver problems (increased liver enzymes) can happen during treatment with RETEVMO and may sometimes be serious. Your healthcare provider will do blood tests before and during treatment with RETEVMO to check for liver problems. Tell your healthcare provider right away if you get any of the following symptoms of liver problems during treatment:

  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark, “tea-colored” urine
  • sleepiness
  • bleeding or bruising
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your stomach area

Lung problems: RETEVMO may cause severe or life-threatening inflammation (swelling) of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you get any new or worsening lung symptoms, including:

  • shortness of breath
  • cough
  • fever

High blood pressure (hypertension): High blood pressure is common with RETEVMO. It may sometimes be severe. You should check your blood pressure regularly during treatment with RETEVMO. If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:

  • confusion
  • headaches
  • shortness of breath
  • dizziness
  • chest pain

Heart rhythm changes (QT prolongation). RETEVMO may cause very slow, very fast, or irregular heartbeats. Your healthcare provider may perform tests before and during treatment with RETEVMO to check the activity of your heart and the levels of body salts (electrolytes) and thyroid-stimulating hormone (TSH) in your blood. Tell your healthcare provider right away if you get any of the following symptoms:

  • loss of consciousness
  • fainting
  • dizziness
  • a change in the way your heart beats (heart palpitations)

Bleeding problems: RETEVMO can cause bleeding, which can be serious and may lead to death. Tell your healthcare provider if you have any signs of bleeding during treatment, including:

  • vomiting blood or if your vomit looks like coffee-grounds
  • pink or brown urine
  • red or black stools that look like tar
  • coughing up blood or blood clots
  • unusual bleeding or bruising of your skin
  • menstrual bleeding that is heavier than normal
  • unusual vaginal bleeding
  • nose bleeds that happen often
  • drowsiness or difficulty being awakened
  • confusion
  • headache
  • change in speech

Allergic reactions: RETEVMO can cause a fever, rash, or pain in muscles or joints, especially during the first month of treatment. Tell your healthcare provider if you get any of these symptoms.

Tumor lysis syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heartbeat. TLS can lead to hospitalization. Your healthcare provider may do blood tests to check you for TLS. You should stay well hydrated during treatment with RETEVMO. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with RETEVMO:

  • nausea
  • vomiting
  • weakness
  • swelling
  • shortness of breath
  • muscle cramps
  • seizures

Risk of wound healing problems: Wounds may not heal well during treatment with RETEVMO. Tell your healthcare provider if you plan to have any surgery before or during treatment with RETEVMO.

  • You should stop taking RETEVMO at least 7 days before planned surgery.
  • Your healthcare provider should tell you when you may start taking RETEVMO again after surgery.

Low thyroid hormone levels in your blood (hypothyroidism). Your healthcare provider will do blood tests to check your thyroid function before and during treatment with RETEVMO. Tell your healthcare provider right away if you develop signs or symptoms of low thyroid hormone levels, including:

  • weight gain
  • feeling cold
  • tiredness that worsens or does not go away
  • constipation

Hip joint problems (slipped capital femoral epiphysis or slipped upper femoral epiphysis) in children. Tell your healthcare provider right away if you develop signs and symptoms of hip problems, including hip or knee pain or a painless limp.

Common side effects

The most common side effects of RETEVMO in adults with solid tumors include:

  • swelling of your arms, legs, hands, and feet (edema)
  • diarrhea
  • tiredness
  • dry mouth
  • stomach-area (abdominal) pain
  • constipation
  • rash
  • nausea
  • headache

The most common side effects of RETEVMO in children 2 years and older with solid tumors include:

  • muscle and bone pain
  • diarrhea
  • nausea
  • bleeding
  • fever
  • stomach-area (abdominal) pain
  • headache
  • vomiting
  • tiredness
  • cough
  • rash
  • coronavirus infection
  • upper respiratory infection
  • swelling

The most common severe abnormal laboratory test results with RETEVMO in adults with solid tumors include decreased white blood cell count, increased liver enzymes, decreased levels of sodium in the blood, and decreased levels of calcium in the blood.

The most common severe abnormal laboratory test results with RETEVMO in children 2 years and older with solid tumors include decreased white blood cell count, decreased levels of calcium in the blood, decreased red blood cell count, increased liver enzymes, decreased levels of magnesium in the blood, and decreased levels of potassium in the blood.

RETEVMO may affect the ability to have children for both females and males. Talk to your healthcare provider if you want to have children and you are thinking about starting treatment with RETEVMO.

  • RETEVMO can harm your unborn baby. You should not become pregnant during treatment with RETEVMO.
  • If you are able to become pregnant:
    • Your healthcare provider will do a pregnancy test before you start treatment with RETEVMO.
    • You should use effective birth control (contraception) during treatment and for 1 week after your last dose of RETEVMO. Talk to your healthcare provider about birth control methods that may be right for you.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RETEVMO.
  • Males with partners who are able to become pregnant should use effective birth control during treatment with RETEVMO and for 1 week after your last dose of RETEVMO.

These are not all the possible side effects with RETEVMO. If you are concerned about side effects, talk to your doctor. Tell your doctor about any side effects you have. You can also report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Before taking RETEVMO, tell your healthcare provider about all your medical conditions, including if you:

  • have liver problems
  • have lung or breathing problems other than lung cancer
  • have high blood pressure
  • have heart problems, including a condition called QT prolongation
  • have bleeding problems
  • plan to have surgery. You should stop taking RETEVMO at least 7 days before your planned surgery.
  • are pregnant or plan to become pregnant. See section above for additional information.
  • are breastfeeding or plan to breastfeed. It is not known if RETEVMO passes into your breast milk. Do not breastfeed during treatment with RETEVMO and for 1 week after your last dose.

Also tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RETEVMO may affect the way other medicines work and other medicines may affect how RETEVMO works, and may increase your risk of side effects.

  • During treatment with RETEVMO, you should avoid taking:
    • St. John’s wort,
    • proton-pump inhibitors (PPIs) such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole,
    • H2 blockers such as famotidine, nizatidine, and cimetidine,
    • antacids that contain aluminum, magnesium, calcium, simethicone, or buffered medicines.

If you cannot avoid taking PPIs, H2 blockers, or antacids, see the “How to take with certain other medicines” section below for more information. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

How to take RETEVMO

  • Take RETEVMO exactly as your healthcare provider tells you.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with RETEVMO if you have side effects. Do not change your dose or stop taking RETEVMO unless your healthcare provider tells you.
  • Swallow RETEVMO capsules and tablets whole. Do not break, crush, or chew.
  • Do not take or give RETEVMO capsules or tablets if you or your child are unable to swallow.
  • If you or your child are unable to swallow RETEVMO whole or if you or your child has a feeding tube, RETEVMO can be prepared and taken or given as a dispersion using only the RETEVMO 40 mg tablets. See the Instructions for Use that comes with RETEVMO for information about the right way to prepare and take or give a dose of RETEVMO 40 mg tablets.
  • Take RETEVMO with or without food.
  • If you vomit after taking a dose of RETEVMO, do not take an extra dose. Take the next dose of RETEVMO at your scheduled time.
  • Do not take a missed dose of RETEVMO unless it is more than 6 hours until your next scheduled dose.
  • If you take too much RETEVMO, call your healthcare provider or go to the nearest hospital emergency room right away.

How to take RETEVMO with certain other medicines

  • If you take a PPI (such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, or rabeprazole), take RETEVMO with food.
  • If you take an H2 blocker (such as famotidine, nizatidine, or cimetidine), take RETEVMO 2 hours before or 10 hours after taking the H2 blocker.
  • If you take an antacid that contains aluminum, magnesium, calcium, simethicone, or buffered medicines, take RETEVMO 2 hours before or 2 hours after taking the antacid.

Learn more

RETEVMO is a prescription medicine available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets. For more information, call 1-800-545-5979 or go to www.Retevmo.com .

This summary provides basic information about RETEVMO. It does not include all information known about this medicine. Read the information that comes with your medicine each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other health care provider about RETEVMO and how to take it. Your doctor is the best person to help you decide if RETEVMO is right for you.

SE CON BS ALL NOV2025

RETEVMO® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

INDICATIONS AND SAFETY SUMMARY

RETEVMO® (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in:
  • adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.
  • adults and children 2 years of age and older with advanced medullary thyroid cancer (MTC) or MTC that has spread, who require a medicine by mouth or injection (systemic therapy).
  • adults and children 2 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy), and who have received radioactive iodine and it did not work or is no longer working.
  • adults and children 2 years of age and older with locally advanced solid tumors (cancers) or solid tumors that have spread, and have gotten worse (progressed) on or after other treatment or there are no satisfactory treatment options.*

Your healthcare provider will perform a test to make sure that RETEVMO is right for you.

  • It is not known if RETEVMO is safe and effective when used in children younger than 2 years of age for the treatment of:
    • advanced MTC or MTC that has spread who require a medicine by mouth or injection.
    • advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection, and have received radioactive iodine and it did not work or is no longer working.
    • locally advanced solid tumors or solid tumors that have spread, and have gotten worse on or after other treatment or there are no satisfactory treatment options.
  • in children for other conditions.

* This use is approved based on how many patients responded to treatment and how long they responded. Studies are ongoing to provide additional information about clinical benefit of Retevmo for this use.

  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap
Need assistance?
Call 1-800-545-5979

This site is intended for US residents aged 18 or older.

Retevmo® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Lilly Support Services™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

CMAT-04223 02/2026 ©Lilly USA, LLC 2026. All rights reserved.

Your Privacy Choices

Cookie Settings

Terms of Use Privacy Statement Consumer Health Privacy Notice Accessibility Statement Sitemap
Lilly logo